Why the study?
Does pimobendan improve hemodynamic parameters and how do they correlate with plasma concentrations in patients with chronic heart failure?
Population
9 patients with chronic heart failure undergoing hemodynamic monitoring
Design
Case_series
Follow-up
4 weeks
Authors
Loading...
Supports hemodynamic improvement with pimobendan in chronic HF; hypothesis-generating and requires randomized confirmation.
Does pimobendan improve hemodynamic parameters and how do they correlate with plasma concentrations in patients with chronic heart failure?
Pimobendan maintenance therapy for 4 weeks significantly improves hemodynamic parameters, including pulmonary capillary wedge pressure and cardiac index, in patients with chronic heart failure.
Hagemeijer et al. (1989) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: